EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Impact of Glucose Metabolism Status on the Association between Apolipoprotein A-I and Ischemic Risk in Patients with Coronary Artery Disease: A Large-Sample Cohort Study

Kailun Yan, Jiawen Li, Kexin Zhang, Menglu Liu, Pei Zhu, Xiaofang Tang, Deshan Yuan, Yuejin Yang, Runlin Gao, Jinqing Yuan, Xueyan Zhao

Endocrinology and Metabolism · 31.12.2025 · 40 (6) · 904-915

DOI: 10.3803/enm.2025.2407 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Endocrinology and Metabolism, erschienen am 31.12.2025. Verfasst von Kailun Yan und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for C…. Hauptthemen laut MEDLINE: Apolipoprotein A-I, Coronary Artery Disease, Blood Glucose, Glucose. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: XPCC Natural Science Support Plan, National High Level Hospital Clinical Research Funding, CAMS Innovation Fund for Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Apolipoprotein A-I (ApoA-I) is a key cardioprotective lipoprotein. Nevertheless, it remains unclear how ApoA-I relates to ischemic risk across glucose metabolism statuses in patients with coronary artery disease (CAD). This study investigated whether glucose metabolism status influences the association between ApoA-I and ischemic risk in CAD patients.

Methods

This cohort study included 10,724 consecutive CAD patients undergoing percutaneous coronary intervention, who were classified into diabetes mellitus (DM), pre-DM, and normal glucose regulation (NGR) groups. The primary clinical endpoint was major adverse cardiac and cerebrovascular event (MACCE), defined as a composite of all-cause death, myocardial infarction, revascularization, and stroke.

Results

Of the 10,232 patients ultimately included, 2,139 (20.9%) experienced MACCE over 5 years. A significant interaction was observed between ApoA-I levels and glucose metabolism status (P for interaction=0.041). In the DM group, an L-shaped association between ApoA-I and MACCE was found, with lower ApoA-I levels linked to a higher risk of MACCE (P for non-linearity= 0.044). Multivariate Cox regression analysis showed that patients in the lowest quintile of ApoA-I had a 1.327-fold increased risk of MACCE compared to those at the lowest risk (hazard ratio, 1.327; 95% confidence interval, 1.097 to 1.604). However, no significant association was observed in the pre-DM or NGR groups (both P>0.05).

Conclusion

This large-scale, 5-year follow-up study is the first to demonstrate that lower ApoA-I levels are associated with increased MACCE risk in CAD patients with DM, highlighting the potential value of ApoA-I in risk stratification and as a therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein A-ICoronary Artery DiseaseBlood GlucoseGlucoseHumansMaleFemaleMiddle AgedAgedCohort StudiesRisk FactorsFollow-Up StudiesDiabetes MellitusPrognosisBiomarkersPercutaneous Coronary Intervention

Stichwörter der Autor:innen

Apolipoprotein A-IDiabetes mellitusGlucose metabolism statusesIschemic riskPercutaneous coronary intervention

Substanzen

Apolipoprotein A-IBlood GlucoseBiomarkersAPOA1 protein, humanGlucose

Autor:innen und Institutionen

  • National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking…

Förderung

  • XPCC Natural Science Support Plan
  • National High Level Hospital Clinical Research Funding
  • CAMS Innovation Fund for Medical Sciences
  • National Clinical Research Center for Cardiovascular Diseases, Fu Wai Hospital, Chinese Academy of Medical Sciences
  • CS Optimizing Antithrombotic Research Fund

Zitieren

APA

Yan, K., Li, J., Zhang, K., Liu, M., Zhu, P., Tang, X., Yuan, D., Yang, Y., Gao, R., Yuan, J., & Zhao, X. (2025). Impact of Glucose Metabolism Status on the Association between Apolipoprotein A-I and Ischemic Risk in Patients with Coronary Artery Disease: A Large-Sample Cohort Study. Endocrinology and Metabolism, 40(6), 904-915. https://doi.org/10.3803/enm.2025.2407

Vancouver

Yan K, Li J, Zhang K, Liu M, Zhu P, Tang X, et al. Impact of Glucose Metabolism Status on the Association between Apolipoprotein A-I and Ischemic Risk in Patients with Coronary Artery Disease: A Large-Sample Cohort Study. Endocrinology and Metabolism. 2025;40(6):904-915. doi:10.3803/enm.2025.2407

BibTeX
@article{Yan2025,
  author = {Yan, Kailun and Li, Jiawen and Zhang, Kexin and Liu, Menglu and Zhu, Pei and Tang, Xiaofang and Yuan, Deshan and Yang, Yuejin and Gao, Runlin and Yuan, Jinqing and Zhao, Xueyan},
  title = {Impact of Glucose Metabolism Status on the Association between Apolipoprotein A-I and Ischemic Risk in Patients with Coronary Artery Disease: A Large-Sample Cohort Study},
  journal = {Endocrinology and Metabolism},
  year = {2025},
  volume = {40},
  number = {6},
  pages = {904--915},
  doi = {10.3803/enm.2025.2407}
}
Kostenlos starten →